Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that leverages its financial strength to beat the competition and two best left off your watchlist.

Two Stocks to Sell:

GE HealthCare (GEHC)

Trailing 12-Month GAAP Operating Margin: 13.4%

Spun off from industrial giant General Electric in 2023 after over a century as its healthcare division, GE HealthCare (NASDAQ: GEHC) provides medical imaging equipment, patient monitoring systems, diagnostic pharmaceuticals, and AI-enabled healthcare solutions to hospitals and clinics worldwide.

Why Are We Cautious About GEHC?

1. The company has faced growth challenges as its 2.7% annual revenue increases over the last two years fell short of other healthcare companies
2. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth

At $70.42 per share, GE HealthCare trades at 14.2x forward P/E. Read our free research report to see why you should think twice about including GEHC in your portfolio.

Northern Trust (NTRS)

Trailing 12-Month GAAP Operating Margin: 28.6%

Founded in 1889 during Chicago's post-Great Fire rebuilding boom, Northern Trust (NASDAQ: NTRS) provides wealth management, asset servicing, and banking solutions to corporations, institutions, families, and high-net-worth individuals globally.

Why Is NTRS Not Exciting?

1. Muted 5.8% annual revenue growth over the last five years shows its demand lagged behind its financials peers
2. Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 9.3% annually

Northern Trust is trading at $142.24 per share, or 13x forward P/E. Dive into our free research report to see why there are better opportunities than NTRS.

One Stock to Watch:

Doximity (DOCS)

Trailing 12-Month GAAP Operating Margin: 37.4%

With over 80% of U.S. physicians as members of its digital community, Doximity (NYSE: DOCS) operates a digital platform that enables physicians and other healthcare professionals to collaborate, stay current with medical news, manage their careers, and conduct virtual patient visits.

Why Are We Fans of DOCS?

1. Annual revenue growth of 29.3% over the past five years was outstanding, reflecting market share gains
2. User-friendly software enables clients to ramp up spending quickly, leading to the speedy recovery of customer acquisition costs
3. DOCS is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders

Doximity’s stock price of $22.94 implies a valuation ratio of 6.7x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.